| Literature DB >> 29587283 |
Ken Haruma1, Tomoari Kamada2, Noriaki Manabe3, Mitsuhiko Suehiro1, Hirofumi Kawamoto1, Akiko Shiotani4.
Abstract
Gastrin acts physiologically as a gut hormone to stimulate acid secretion after meal and as a cell-growth factor of oxyntic mucosa. Increase in serum gastrin level happens under various conditions including Zollinger-Ellison syndrome, antral G cell hyperplasia, autoimmune gastritis, atrophic gastritis, renal failure, vagotomy, Helicobacter pylori infection and acid suppressive therapy. As acid suppressive therapy causes hypergastrinemia, the association between acid suppressive therapy and gastric neuroendocrine cell tumor (NET) has been discussed during the past 30 years. In this review article, the definition of hypergastrinemia and the related disorders including acid suppressive therapy and gastric NET are discussed.Entities:
Keywords: Gastric neuroendocrine cell tumor; Gastrin; Hypergastrinemia; Proton pump inhibitor
Mesh:
Substances:
Year: 2018 PMID: 29587283 DOI: 10.1159/000485734
Source DB: PubMed Journal: Digestion ISSN: 0012-2823 Impact factor: 3.216